Predictive power of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score for mortality in cirrhotic

Damian Piotrowski1, Anna Sączewska-Piotrowska2, Jerzy Jaroszewicz1

  • 1Medical University of Silesia in Katowice, Poland.

Insights

Changes in Child-Turcotte-Pugh (CTP) and Model for End-Stage Liver Disease (MELD) scores during hospitalization effectively predict in-hospital mortality in liver cirrhosis patients. Kinetics of these scores offer valuable prognostic insights.

Area of Science:

  • Hepatology
  • Internal Medicine
  • Clinical Prediction Models

Background:

  • Liver cirrhosis poses a significant risk for in-hospital mortality.
  • Accurate prediction of mortality is crucial for patient management.

Purpose of the Study:

  • To evaluate the predictive performance of Child-Turcotte-Pugh (CTP) and Model for End-Stage Liver Disease (MELD) score kinetics during hospitalization for in-hospital mortality in liver cirrhosis patients.

Main Methods:

  • Retrospective analysis of 174 hospitalized liver cirrhosis patients.
  • Calculation of CTP and MELD scores at admission and their changes (ΔCTP, ΔMELD).
  • Logistic regression, ROC curve analysis, and survival analysis were employed.

Main Results:

  • ΔMELD ≥ 1 showed the highest AUC in univariate analysis, followed by ΔCTP ≥ 1.
  • Multivariate models incorporating score kinetics demonstrated outstanding predictive ability for in-hospital mortality.

Conclusions:

  • In-hospital mortality is a significant concern in liver cirrhosis.
  • Combining CTP and MELD scores with their kinetic changes improves short-term mortality prediction in these patients.
Abstract

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K
Introduction to z Scores01:06

Introduction to z Scores

A z score (or standardized value) is measured in units of the standard deviation. It tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one.
z scores...
11.2K
Introduction to z Scores01:05

Introduction to z Scores

A z score (or standardized value) is measured in units of the standard deviation. It indicates how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one.
z scores...
1.3K
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
19.6K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
45.8K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
199